Technology Transfer
Technologies protected in 2023
40
ICREA | ||
---|---|---|
EXPERIMENTAL SCIENCES & MATHEMATICS |
||
Núria Aliaga (ICMAB-CSIC) |
|
|
Xavier Barril (UB) |
|
|
Jens Biegert (ICFO) |
|
|
Gustau Catalán (ICN2) |
|
|
José Ramón Galán-Mascarós (ICIQ) |
|
|
Antón Vidal i Ferran (UB) |
|
|
ENGINEERING SCIENCES | ||
Xavier Costa Pérez (I2CAT) |
|
|
Gerasimos Konstantatos (ICFO) |
|
|
Arben Merkoçi (ICN2) |
|
|
Josep Nogués Sanmiquel (ICN2) |
|
|
Valerio Pruneri (ICFO) |
|
|
Samuel Sánchez Ordóñez (IBEC) |
|
|
Jordi Sort Viñas (UAB) |
|
|
Albert Tarancón (IREC) |
|
|
LIFE & MEDICAL SCIENCES | ||
Joaquín Arribas (PSMAR & VHIO) |
|
|
Christian Brander (IRSICaixa) |
|
|
Josep Dalmau (IDIBAPS) |
|
|
Xavier Daura Ribera (UAB) |
|
|
Roger Gomis (IRB Barcelona) |
|
|
Pau Gorostiza Langa (IBEC) |
|
|
Iñaki Martín-Subero (IDIBAPS) |
|
|
Javier Martínez-Picado (IRSICaixa) |
|
|
Pablo Menéndez (IJC) |
|
|
Aurora Pujol Onofre (IDIBELL) |
|
|
Ángel Raya Chamorro (IDIBELL) |
|
|
Luis Serrano (CRG) |
|
|
Manuel Serrano (IRB Barcelona) |
|
|
Laura Soucek (VHIO) |
|
Spin-off companies
1
Nanobots Therapeutics
Supported by the Institut de Bioenginyeria de Catalunya (IBEC) and ICREA
Entrepreneur: ICREA Research Professor Samuel Sánchez Ordóñez
Born in January 2023
Nanobots Therapeutics is a biomedical company developing a new modality of medicines for different types of cancers, based on our unique platform technology (MotionTx).
Our mission is to develop more effective therapies for patients by increasing drug penetration into cancer cells.
We’re utilizing our proprietary MotionTx technology platform to design, engineer, and develop therapeutics that combine the high and selective tumor penetration with the precision of targeted therapies in order to reach and kill cancer cells.